Abstract

Background and Hypothesis

In patients with schizophrenia spectrum disorder (SSD), the lifetime prevalence of self-harm (SH) and non-suicidal self-injury (NSSI) is currently uncertain. The primary aim of this review was to provide a synthesis of the existing literature concerning the prevalence of SH/NSSI in individuals with SSD, and individuals at clinical high risk of psychosis (CHR-P). Secondary aims were to investigate methods, severity, and functions of self-injurious behavior in these populations.

Study Design

Studies quantifying the prevalence of SH/NSSI in individuals with SSD or at CHR-P were included in this review. MEDLINE, EMBASE, and PsycInfo were searched for eligible studies June 10, 2022 and systematically screened by two independent reviewers. Risk of bias was assessed using the Joana Briggs Institute Critical Appraisal Checklist for Prevalence Studies by two independent reviewers. A meta-analysis of the lifetime prevalence of SH/NSSI was conducted using generalized linear mixed model with the logit transformation.

Study Results

Thirty-two studies were included in this review (n = 15 440), 4 of which included individuals at CHR-P (n = 397). The meta-analysis showed a pooled lifetime prevalence of SH of 31.0% (95% CI: 22.1%; 41.6%) in individuals with SSD (n = 2822) and 39.7% (95% CI: 17.5%; 70.0%) in individuals at CHR-P (n = 397). These estimates should be interpreted with caution due to substantial heterogeneity. Cutting was the most frequent method of SH/NSSI and SH command hallucinations may be an overlooked cause of self-injurious behavior in these patients.

Conclusions

Self-injurious behavior is a highly prevalent, and possibly overlooked concern, in individuals with SSD and at CHR-P.

Introduction

Schizophrenia is a prevalent psychotic disorder with an annual incidence rate of 0.2–0.4/1000 and a lifetime prevalence of 1%–2%.1–3 The illness constitutes 1.1% of the total disability adjusted life years worldwide and 2.8% of the years lived with disability worldwide,4 posing a detrimental health care burden.5

Self-injurious behavior is likewise a serious public health concern with a suggested prevalence of 6% in adults6 and 16%–18% in adolescents7 in the general population, however, the prevalence may be as high as 40%–80% in clinical psychiatric populations.8 Self-injurious behavior is linked to an increased risk of suicidal ideation,9 suicide attempts,10 and suicide.11 Conversely, suicidal behavior in individuals with psychotic disorders, in particular schizophrenia, has been thoroughly examined, displaying a high risk of lifetime risk of suicidal ideation,12 suicide attempt,13 and suicide.14 Thus, in addition to numerous deleterious consequences including severe scarring, contraction of infectious diseases, and accidental death, self-injurious behavior may facilitate genuine suicidal behavior in individuals with schizophrenia.15

A diverse terminology concerning the concept of self-injurious behavior has appeared in past literature, eg, syndrome of self-cutting, deliberate self-harm (SH), self-wounding, and self-mutilation.16 Sometimes different terms have been used interchangeably to reference a single concept, while other times a single term has been used to reference several different concepts. This lack of consensus regarding the terminology has limited the quantification and understanding of self-injurious behavior.17 This review will distinguish between two main concepts: non-suicidal self-injury (NSSI) and SH. NSSI is defined as “the deliberate, self-inflicted damage of body tissue without suicidal intent and for purposes not socially or culturally sanctioned”.18 Most individuals engaged in NSSI employ multiple methods of self-injury—primarily skin-cutting (70%–90%), head banging/hitting (21%–44%), and self-burning (15–35%).15 SH is understood as “self-poisoning or self-injury, irrespective of the apparent purpose of the act” 19 and consequently does not discriminate between self-injurious behavior with and without suicidal intent. Although some overlapping features exist between NSSI and suicidal behavior, recognition of NSSI and suicidal behavior as discrete entities is evidenced by significant differences in terms of etiology, psychiatric impairment, psychological function, method of self-injury, and outcome.15,20

Previous studies have suggested that self-injurious behavior is prevalent among individuals with schizophrenia,21,22 however, to the knowledge of the authors, no systematic review or meta-analysis examining the prevalence of NSSI in this patient group exits. Understanding the association between schizophrenia and self-injurious behavior could help identify subgroups of patients with schizophrenia that are responsive to different treatment modalities including pharmacological and psychosocial treatment as well as psychotherapy.

Aim

The primary aim of this study is to provide a systematic review and meta-analysis of the lifetime prevalence of self-injurious behavior, including in relation to compliance with SH command hallucinations, in individuals diagnosed with a schizophrenia spectrum disorder (SSD) and individuals at clinical high risk of psychosis (CHR-P), respectively.

The secondary aims are to investigate methods, severity, and functions of self-injurious behavior in these populations.

Methods

Protocol and Registration

The study protocol was registered at the International Prospective Register of Systematic Reviews (PROSPERO) (ID: CRD42021264713), and the review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines (PRISMA 2020) and the Meta-analysis of Observational Studies in Epidemiology 2000 checklist (MOOSE) (see checklists in supplementary materials 1 and 2). PRISMA 2020 is an evidence-based checklist of items aimed at aiding transparent and complete reporting in systematic reviews.23 Amendments to the study protocol are stated in supplementary material 3.

Search Strategy

The following electronic bibliographic databases were searched for relevant studies: MEDLINE (PubMed), EMBASE, and PsycInfo. A comprehensive search was conducted on October 6, 2022, using keywords and medical subject headings for self-injurious behavior, eg, self-injur* and “Self Mutilation”[Mesh], which were cross-referenced with keywords and medical subject headings for schizophrenia, eg, schizophren* and “Schizophrenia”[Mesh] (Full search strategy is available in supplementary material 4). The search was limited to articles in the English language. Furthermore, references within relevant previously published reviews on the subject were hand-searched for additional eligible studies. Endnote was used to merge retrieved references.

Abstracts and titles retrieved from the systematic search and those retrieved from additional sources were screened for eligibility by two independent reviewers (EAL and JNK) using the software Covidence.24 The full texts of studies deemed potentially eligible were independently evaluated by the two reviewers (EAL and JNK). Any disagreements between the two reviews were resolved by discussion. If no consensus could be reached, a third reviewer decided on the matter (OM).

Eligibility Criteria

Studies were eligible for the review if (1) participants were adults (18 years or older) meeting any recognized diagnostic criteria (eg, ICD-10 or DSM-V) for an SSD, ie, non-organic, non-affective psychotic disorder (thus excluding schizoaffective disorders), or meeting the criteria for CHR-P assessed using the Comprehensive Assessment of At-Risk Mental States (CAARMS),25 (2) if either SH or NSSI was quantified in the study by either a SH questionnaire, a single item in a questionnaire, or a structured/semi-structured interview, and (3) if the article was in the English language. All study designs were included in the review.

Studies were excluded if (1) more than 25% of participants did not have an SSD, eg, schizoaffective disorder or bipolar affective disorder, or were not at CHR-P, (2) participants were co-diagnosed with a severe intellectual disability, (3) self-injury was considered stereotyped self-injurious behavior as seen in autistic spectrum disorder, and (4) or self-injury data was quantified solely through chart review. The decision to include individuals at CHR-P and to include studies with at least 75% of participants with SSD was made post hoc.

Data Extraction

Data were extracted using a standardized data-collection form. From all studies, the prevalence of self-injurious behavior, independent of the period-of-interest, was extracted, however, only lifetime prevalence was included in the meta-analysis. In studies where the prevalence of self-injurious behavior was reported solely as a percentage, the numerator and denominator were estimated using the sample size. Additional extracted data included: Study characteristics (authors, country, year of study publication, study design [including possible follow-up time], sample source, sample size, and a possible comparison sample); methods, functions and severity of self-injurious behavior; demographic variables possibly correlating to SH/NSSI (sample age, sample sex, family history of SH, alcohol abuse, and substance abuse); and clinical variables possibly correlating to self-injurious behavior (global assessment of functioning-score, assessment of negative symptoms (eg, Scale for the Assessment of Negative Symptoms,26 Positive and negative Syndrome Scale [PANSS] negative subscale),27 assessment of positive symptoms (eg, PANSS positive subscale),27 and assessment of depressive symptoms (eg, Calgary Depression Scale for Schizophrenia).28

If insufficient data were reported, the authors were contacted by e-mail to retrieve any missing data granted that the study was no more than 10 years old. If no data were available after request, the study was excluded. Extraction of data was performed and recorded in a predefined data-collection form by EAL.

Risk of Bias Assessment

In the included studies, the risk of bias was independently assessed by two independent reviewers [Eva Amanda Lorentzen (EAL) and Jesper Nørgaard Kjær (JNK)]. Any disagreements between the two reviews were resolved by discussion. If no consensus could be reached, a third reviewer decided on the matter [Ole Mors (OM)]. Risk of bias was assessed using the Joana Briggs Institute Critical Appraisal Checklist for Prevalence Studies.29 Through a nine-item checklist, it takes into consideration the following characteristics: (1) appropriate study size, setting, and sampling, (2) sufficient coverage of the identified sample in data analysis, (3) validity and reliability of methods for identification and measurement of the study condition, (4) appropriate statistical analysis, and (5) adequate response rate. This tool was chosen, as it is applicable to observational studies.29,30

Risk of publication bias across studies was investigated using a funnel plot. Egger’s linear regression was used to quantitatively analyze a possible asymmetry, where a P value <.1 suggests a statistically significant risk of publication bias.31

Data Synthesis and Analysis

A meta-analysis of the lifetime prevalence of SH and NSSI was conducted. The lifetime prevalence of self-injurious behavior was pooled using generalized linear mixed model with the logit transformation in the groups with an SSD and CHR-P, respectively. An outlier analysis was conducted for both meta-analyses. The decision to use a generalized linear mixed model was made post hoc. Due to a lack of consensus on the area, the prevalence estimate pooled using the inverse variance method with the Freeman–Tukey transformation was also performed. Also, to control for possible confounding a subgroup analysis was performed for the lifetime prevalence of self-injurious behavior in the group with an SSD with stratification into 2 groups: (1) NSSI and (2) self-injurious behavior excluding NSSI. Forest plots were created for all meta-analyses to provide a graphical overview of the data. Due to scarcity of data more elaborate subgroup or meta-regression analyses could not be performed. Percentage of variability due to heterogeneity rather than a sampling error was judged using the statistic with a -value of 25%, 50%, and 75% respectively representing low, medium, and high level of heterogeneity.32 All analyses were conducted using R studio “Ghost Orchid” Release (077589bcad3467ae79f318afe8641a1899a51606, 2021-09-20) for macOS.33 The following packages were used: “tidyverse”, “meta”, and “devtools”.

Results

Study Selection

An overview of the study selection process is provided in figure 1. The search of electronic databases (MEDLINE [PubMed], EMBASE, and PsycInfo) yielded 2328 articles after duplicate removal, which were screened for eligibility by title and abstract. In the initial screening 2156 articles were deemed irrelevant leaving 172 articles to be assessed in full text. Of those who did 130 articles did not meet the eligibility criteria and were thus excluded. Further 3 articles were excluded due to a large proportion of the study population not meeting the criterium of SSD.34–36 Ten articles35,37–45 reported insufficient data and the authors were contacted by e-mail requesting additional data. The most common causes for missing data were a population with mixed diagnoses and self-injurious behavior reported as a score rather than a proportion. Of these, two provided data38,41 with the remaining articles not being able to supply the missing data or not responding to our requests. One additional article46 was found through hand-searching references from previously published reviews. The search strategy yielded a total of 32 included articles.37,38,41–44,46–69

Flow chart of the selection and screening of studies for review and meta-analysis.
Fig. 1.

Flow chart of the selection and screening of studies for review and meta-analysis.

Study Characteristics

All included studies are described in Table 1. A total of 15 440 individuals were included. Eleven studies included solely individuals with an schizophrenia, and the remaining studies included populations with a mixed diagnostic composition. The most frequent diagnoses, apart from schizophrenia, were schizoaffective disorder, bipolar disorder, and psychosis not otherwise specified. Four studies included CHR-P individuals. Three of the included studies included data on methods, severity, and functions of self-injurious behavior. Three studies only examined self-injurious behavior in relation to compliance with SH command hallucinations. Twenty-six of the included studies were conducted in Western countries and seven studies were conducted in Non-western countries. Studies were overwhelmingly cross-sectional, and participants were mostly males stemming from inpatient, outpatient, and prison populations. Seventeen of the included studies clearly stated the instrument used to quantify self-injurious behavior.

Table 1.

Characteristics of all included studies.

Author Year, CountryDesignSample SourceNDiagnostic CompositionAge% MaleDefinition of Self-injurious BehaviorSelf-injury InstrumentSelf-injury Time PeriodPrevalence of Self-injurious Behavior
Barrowcliff 2010, United Kingdom46Cross-sectionalCommunity, inpatients29Schizophrenia or schizoaffective disorder with documented reports of auditory hallucinations in the previous month36.7 (11.8) (all individuals with command hallucinations)59.2% (all individuals with command hallucinations)Compliance with last self-harm command hallucinationCommand Hallucination Interview (CHI)31.0% (9/29)
Barrowclough 2010, United Kingdom47Randomized controlled trail (data from control arm)Patients with contact to NHS mental health trusts135Schizophrenia 81,7%; schizophreniform disorder 1.2%; psychosis NOS 8,9%; schizoaffective disorder 8.3% (at baseline)38.3 (10.0)84.0%SHBrief structured interview (not clearly specified)Past 12 mo11.9% (16/135)
Biswas 2006, India48Cross-sectionalOutpatients20Schizophrenia only31.5 (8.4)50.0%Self mutilatory/ injurious behavior, not otherwise specified (SH)Non-psychotic domain of Interview for the Retrospective Assessment of the Onset and Course of Schizophrenia and Other Psychoses (IRAOS)15.0% (3/20)
Dugré 2017, Canada37Cross-sectionalInpatients29Schizophrenia spectrum disorder30.28 (5.99) (all individuals in study)34.15% (all individuals in study)Compliance with self-harm command hallucinationsAuditory hallucinations schedule (AHS)Past 2 mo27.6% (8/29)
Grattan 2019, United States38Cross-sectionalOutpatients99Schizophrenia spectrum disorder12–3572.2% (all individuals in study)NSSIColumbia- Suicide Severity Scale (C-SSRS)Lifetime14.1% (14/99)
Güney 2020, Turkey49Cross-sectionalInpatients, outpatients, patienting contacting emergency psychiatric services165Schizophrenia 46.7% (77/165); psychosis NOS 35.8% (59/165); schizoaffective disorder 13.3% (22/165), substance- induced psychosis 4.2% (69/165)No NSSI: 20–65 (min–max) 40 (median); NSSI: 18–60 (min–max) 33 (median)72.2%NSSIInventory of Statements about Self- injury (ISAS)Lifetime43.6% (72/165)
Guo 2021, China70Cross-sectionalForensic Psychiatric Hospital389Schizophrenia 91.2% (372/408)44.3 (9.1)73.8%SHA standard questionnaire (not clearly specified)Lifetime7.7% (30/389)
Haining 2020, United Kingdom50Cross-sectionalYouth Mental Health Risk and Resilience study (YouR)145CHR-P: 89,7%; first episode of psychosis (FEP): 10,3%CHR-P: 21.6 (4.3); FEP: 23.7 (4.8)CHR-P: 6.0% FEP: 90.0%SH, suicide attempts includedComprehensive Assessment of At-Risk Mental States (CAARMS)Lifetime
Past month
CHR-P: 28.5% (38/130); FEP: 60.0% (9/15)
CHR-P: 5.4% (7/130; FEP: 20.0% (3/15)
Harvey 2008, United Kingdom51Cross-sectionalÆSOP (Aetiology and Ethnicity in Schizophrenia and Other Psychoses)496Schizophrenia spectrum disorder 72.2%; 27.8% mania or depressive psychosis30.8 (10.8)57.7%Attempted suicide or bodily harmPsychiatric and Personal History Schedule (PPHS)Lifetime
Between the onset of their psychotic symptoms and their first presentation to services
5.83% (29/496) (entire population)
9.21% (45/496) (schizophrenia spectrum disorder only)
Heslin 2016, United Kingdom52Prospective (including baseline cross-sectional data)ÆSOP (Aetiology and Ethnicity in Schizophrenia and Other Psychoses)163Schizophrenia only29 (median)64.2%SHWHO life chartLifetime12.9% (21/163)
Hunter 2009, United Kingdom53Prospective (including baseline cross-sectional data)NHS Health Boards in Scotland1015Schizophrenia 93.1%; schizotypal disorder, persistent delusional disorders, acute and transient psychotic disorders, and induced delusional disorder 2.0%; schizoaffective disorder 4.9%43 (11)70.0%SHHealth of the Nation Outcome Scales (HONOS)Past 12 mo8.9% (90/1015)
Jakhar 2015, India50Cross-sectionalInpatients270Schizophrenia only34.01 (9.883)64.8%SHRam Manohar Lohia Risk Assessment Interview31.4% (85/270)
Jarret 2016, United Kingdom54Cross-sectionalInmates in local London Prisons61CHR-P: 63.8%; FEP: 26.0%CHR-P: 27.5 (5.8); FEP: 27.7 (5.6)100.0%SHComprehensive Assessment of At-Risk Mental States (CAARMS)Lifetime
Past 12 mos
CHR-P: 25.0% (11/44); FEP: 32.0% (8/25)
CHR-P: 9.1% (4/44); FEP: 16.0% (4/25)
Koyanagi 2015, Japan44Cross-sectionalAdult Psychiatric Morbidity Survey 20077403Self-reported symptoms of mania/hypomania, thought control, paranoia, strange experiences, and auditory hallucinations16–34: 30.7%; 35–59: 42.9%; >60: 26.4%48.6% (all individuals)NSSILifetimeMania/hypomania 20.5%; paranoia 25.5%; strange experience 21.1%; auditory hallucination 32.5%
Laporte 2021, Sweden71Cross-sectionalForensic psychiatric patients70Schizophrenia spectrum and other psychotic disorders34.9 (10.7) (all individuals)86.7% (all individuals)SHInventory of Statements About Self- injury (ISAS)Lifetime46/70 (65.7%)
Lee 2012, China55Cross-sectionalTaiwan’s NHI program with a diagnosis of schizophrenia1655Self-reported schizophrenia only43.9 (12.2) (all individuals)59.2% (all individuals)SH10-item risk assessment inventory (not clearly specified)Past 12 mo1.9% (32/1655)
Lee 2004, Singapore56Cross-sectionalInpatients53Schizophrenia with command hallucinations in the past 6 mo only39.1 (9.7) (all individuals)45%Self-injurious acts in compliance with command hallucinationsSemi-structured questionnaire (not clearly specified)Past 6 mo11.3% (6/53)
Markovitz 1991, United States57Prospective (including baseline cross-sectional data)Outpatients14Schizotypal personality disorder only 28.6% (4/14); Schizotypal personality disorder and borderline personality disorder 71.4% (10/14)34.4 (6.9) (all individuals)40.9% (all individuals)Cutting onlyShort questionnaire (not clearly specified)Past 6 wkSchizotypal disorder: 50.0% (2/4)
Schizotypal disorder and borderline personality disorder: 70.0% (7/10)
Miles 2003, United Kingdom58Cross-sectionalCOMO randomized controlled trial16071.50% schizophrenia spectrum; 11.21 bipolar affective disorder; 17,29% other psychosis39 (11.1)83.2%SHLifetime29.0% (46/160)
Monahan 2017, United States41Prospective (including baseline cross-sectional data)MacArthur Violence Risk Assessment Study177Schizophrenia only18–40 (all individuals)57.6% (all individuals)NSSI and SHStructured interview (not clearly specified)2 mo prior to baseline
12 mo follow up
NSSI: 7.3% (13/177)
Deliberate self- harm: 15.8% (28/177)
Mork 2013, Norway42Cross-sectionalThematically Organized Psychosis (TOP) Study251Schizophrenia spectrum disorder30.1 (9.8)85.0%NSSI and SHQuestionnaire adapted from CASE-studyLifetimeNSSI: 29.9% (75/251); SH: 14.3% (36/251)
Mork 2012, Norway59Cross-sectionalTOP Study388Schizophrenia 76.2%; schizophreniform disorder 8.2%; schizoaffective disorder 15.5%31 (9.9)57.2%SHQuestionnaire adapted from CASE-studyLifetimeAt least one life-time episode of SH: 48.5% (188/388); Multiple episodes of SH: 28.1% (109/388)
Neeleman 1994, United States60Cross-sectionalOutpatients21Schizophrenia only45 (12.6)48.0%SH43.0% (9/21)
Nijman 1999, Netherlands61Cross-sectionalInpatients14Schizophrenia only37.5 (12.4) (all individuals)52.0% (all individuals)NSSILifetime57.1% (8/14)
Ose 2021, Norway62Cross-sectionalOutpatients1635Schizophrenia only37.0%NSSIPast month7.2% (117/1635)
Phillips 2009, Australia45Randomized controlled trail (including baseline cross-sectional data)PACE clinic193CHR-P onlyCogther + risp: 17.6 (3.0); CogTher + placebo 18.0 (2.7); Supp + placebo 18.8 (3.7); monitoring 17.8 (2.6)39.4%SHLifetime64.8% (125/193)
Pluck 2012, United Kingdom63Cross-sectionalCommunity, inpatients87Schizophrenia onlySelf-harm- group: 40.1 (11.0); non-self- harm-group: 9.3 (12.7)90.%SHDeliberate Self- Harm Inventory (SHI)Lifetime68.0% (59/87)
Salim 2021, Lebanon71Cross-sectionalOutpatients93Schizophrenia only with command hallucinations55.9 (11.3)64.5%SHAggression scale (not clearly specified)23.7% (22/93)
Simms 2007, United Kingdom65Cross-sectionalInpatients33Schizophrenia onlySelf-harm group: 37.5 (8.4); non- self-harm group: 32.8 (14.7)66.7%SHLifetime51.5% (17/33)
Upthegrove 2010, United Kingdom66Cross-sectionalEarly Intervention Service (EIS)92Schizophrenia 70.0%; delusional disorder 4.3%; acute and transient psychotic disorder 8.7%; other non- organic psychotic disorder 3.3%; schizoaffective disorder 2.2%; mania with psychotic symptoms 7.6%; depressive disorder severe with psychotic symptoms 3.3%22.5 (4.8)75.0%SHSuicide attempt-self- injury interview II (SAS-II)Lifetime
12 mo following the first episode of psychosis
33.0% (30/92)
6.5% (6/92)
Verdolini 2017, Italy43Cross-sectionalInmates in Spoleto Prison25Schizophrenia spectrum disorder18 and older100.0%SHDeliberate Self- Harm Inventory (SHI)Lifetime32.0% (8/25)
Zimbrón 2013, United Kingdom67Cross-sectionalCameo Early Intervention Services60CHR-P 50.0%; FEP 50.0%CHR-P: 21.7 (4.2); FEP: 22.0 (4.2)60.0%SHLifetimeCHR-P: 40.0% (12/30); FEP: 23.3% (7/30)
Author Year, CountryDesignSample SourceNDiagnostic CompositionAge% MaleDefinition of Self-injurious BehaviorSelf-injury InstrumentSelf-injury Time PeriodPrevalence of Self-injurious Behavior
Barrowcliff 2010, United Kingdom46Cross-sectionalCommunity, inpatients29Schizophrenia or schizoaffective disorder with documented reports of auditory hallucinations in the previous month36.7 (11.8) (all individuals with command hallucinations)59.2% (all individuals with command hallucinations)Compliance with last self-harm command hallucinationCommand Hallucination Interview (CHI)31.0% (9/29)
Barrowclough 2010, United Kingdom47Randomized controlled trail (data from control arm)Patients with contact to NHS mental health trusts135Schizophrenia 81,7%; schizophreniform disorder 1.2%; psychosis NOS 8,9%; schizoaffective disorder 8.3% (at baseline)38.3 (10.0)84.0%SHBrief structured interview (not clearly specified)Past 12 mo11.9% (16/135)
Biswas 2006, India48Cross-sectionalOutpatients20Schizophrenia only31.5 (8.4)50.0%Self mutilatory/ injurious behavior, not otherwise specified (SH)Non-psychotic domain of Interview for the Retrospective Assessment of the Onset and Course of Schizophrenia and Other Psychoses (IRAOS)15.0% (3/20)
Dugré 2017, Canada37Cross-sectionalInpatients29Schizophrenia spectrum disorder30.28 (5.99) (all individuals in study)34.15% (all individuals in study)Compliance with self-harm command hallucinationsAuditory hallucinations schedule (AHS)Past 2 mo27.6% (8/29)
Grattan 2019, United States38Cross-sectionalOutpatients99Schizophrenia spectrum disorder12–3572.2% (all individuals in study)NSSIColumbia- Suicide Severity Scale (C-SSRS)Lifetime14.1% (14/99)
Güney 2020, Turkey49Cross-sectionalInpatients, outpatients, patienting contacting emergency psychiatric services165Schizophrenia 46.7% (77/165); psychosis NOS 35.8% (59/165); schizoaffective disorder 13.3% (22/165), substance- induced psychosis 4.2% (69/165)No NSSI: 20–65 (min–max) 40 (median); NSSI: 18–60 (min–max) 33 (median)72.2%NSSIInventory of Statements about Self- injury (ISAS)Lifetime43.6% (72/165)
Guo 2021, China70Cross-sectionalForensic Psychiatric Hospital389Schizophrenia 91.2% (372/408)44.3 (9.1)73.8%SHA standard questionnaire (not clearly specified)Lifetime7.7% (30/389)
Haining 2020, United Kingdom50Cross-sectionalYouth Mental Health Risk and Resilience study (YouR)145CHR-P: 89,7%; first episode of psychosis (FEP): 10,3%CHR-P: 21.6 (4.3); FEP: 23.7 (4.8)CHR-P: 6.0% FEP: 90.0%SH, suicide attempts includedComprehensive Assessment of At-Risk Mental States (CAARMS)Lifetime
Past month
CHR-P: 28.5% (38/130); FEP: 60.0% (9/15)
CHR-P: 5.4% (7/130; FEP: 20.0% (3/15)
Harvey 2008, United Kingdom51Cross-sectionalÆSOP (Aetiology and Ethnicity in Schizophrenia and Other Psychoses)496Schizophrenia spectrum disorder 72.2%; 27.8% mania or depressive psychosis30.8 (10.8)57.7%Attempted suicide or bodily harmPsychiatric and Personal History Schedule (PPHS)Lifetime
Between the onset of their psychotic symptoms and their first presentation to services
5.83% (29/496) (entire population)
9.21% (45/496) (schizophrenia spectrum disorder only)
Heslin 2016, United Kingdom52Prospective (including baseline cross-sectional data)ÆSOP (Aetiology and Ethnicity in Schizophrenia and Other Psychoses)163Schizophrenia only29 (median)64.2%SHWHO life chartLifetime12.9% (21/163)
Hunter 2009, United Kingdom53Prospective (including baseline cross-sectional data)NHS Health Boards in Scotland1015Schizophrenia 93.1%; schizotypal disorder, persistent delusional disorders, acute and transient psychotic disorders, and induced delusional disorder 2.0%; schizoaffective disorder 4.9%43 (11)70.0%SHHealth of the Nation Outcome Scales (HONOS)Past 12 mo8.9% (90/1015)
Jakhar 2015, India50Cross-sectionalInpatients270Schizophrenia only34.01 (9.883)64.8%SHRam Manohar Lohia Risk Assessment Interview31.4% (85/270)
Jarret 2016, United Kingdom54Cross-sectionalInmates in local London Prisons61CHR-P: 63.8%; FEP: 26.0%CHR-P: 27.5 (5.8); FEP: 27.7 (5.6)100.0%SHComprehensive Assessment of At-Risk Mental States (CAARMS)Lifetime
Past 12 mos
CHR-P: 25.0% (11/44); FEP: 32.0% (8/25)
CHR-P: 9.1% (4/44); FEP: 16.0% (4/25)
Koyanagi 2015, Japan44Cross-sectionalAdult Psychiatric Morbidity Survey 20077403Self-reported symptoms of mania/hypomania, thought control, paranoia, strange experiences, and auditory hallucinations16–34: 30.7%; 35–59: 42.9%; >60: 26.4%48.6% (all individuals)NSSILifetimeMania/hypomania 20.5%; paranoia 25.5%; strange experience 21.1%; auditory hallucination 32.5%
Laporte 2021, Sweden71Cross-sectionalForensic psychiatric patients70Schizophrenia spectrum and other psychotic disorders34.9 (10.7) (all individuals)86.7% (all individuals)SHInventory of Statements About Self- injury (ISAS)Lifetime46/70 (65.7%)
Lee 2012, China55Cross-sectionalTaiwan’s NHI program with a diagnosis of schizophrenia1655Self-reported schizophrenia only43.9 (12.2) (all individuals)59.2% (all individuals)SH10-item risk assessment inventory (not clearly specified)Past 12 mo1.9% (32/1655)
Lee 2004, Singapore56Cross-sectionalInpatients53Schizophrenia with command hallucinations in the past 6 mo only39.1 (9.7) (all individuals)45%Self-injurious acts in compliance with command hallucinationsSemi-structured questionnaire (not clearly specified)Past 6 mo11.3% (6/53)
Markovitz 1991, United States57Prospective (including baseline cross-sectional data)Outpatients14Schizotypal personality disorder only 28.6% (4/14); Schizotypal personality disorder and borderline personality disorder 71.4% (10/14)34.4 (6.9) (all individuals)40.9% (all individuals)Cutting onlyShort questionnaire (not clearly specified)Past 6 wkSchizotypal disorder: 50.0% (2/4)
Schizotypal disorder and borderline personality disorder: 70.0% (7/10)
Miles 2003, United Kingdom58Cross-sectionalCOMO randomized controlled trial16071.50% schizophrenia spectrum; 11.21 bipolar affective disorder; 17,29% other psychosis39 (11.1)83.2%SHLifetime29.0% (46/160)
Monahan 2017, United States41Prospective (including baseline cross-sectional data)MacArthur Violence Risk Assessment Study177Schizophrenia only18–40 (all individuals)57.6% (all individuals)NSSI and SHStructured interview (not clearly specified)2 mo prior to baseline
12 mo follow up
NSSI: 7.3% (13/177)
Deliberate self- harm: 15.8% (28/177)
Mork 2013, Norway42Cross-sectionalThematically Organized Psychosis (TOP) Study251Schizophrenia spectrum disorder30.1 (9.8)85.0%NSSI and SHQuestionnaire adapted from CASE-studyLifetimeNSSI: 29.9% (75/251); SH: 14.3% (36/251)
Mork 2012, Norway59Cross-sectionalTOP Study388Schizophrenia 76.2%; schizophreniform disorder 8.2%; schizoaffective disorder 15.5%31 (9.9)57.2%SHQuestionnaire adapted from CASE-studyLifetimeAt least one life-time episode of SH: 48.5% (188/388); Multiple episodes of SH: 28.1% (109/388)
Neeleman 1994, United States60Cross-sectionalOutpatients21Schizophrenia only45 (12.6)48.0%SH43.0% (9/21)
Nijman 1999, Netherlands61Cross-sectionalInpatients14Schizophrenia only37.5 (12.4) (all individuals)52.0% (all individuals)NSSILifetime57.1% (8/14)
Ose 2021, Norway62Cross-sectionalOutpatients1635Schizophrenia only37.0%NSSIPast month7.2% (117/1635)
Phillips 2009, Australia45Randomized controlled trail (including baseline cross-sectional data)PACE clinic193CHR-P onlyCogther + risp: 17.6 (3.0); CogTher + placebo 18.0 (2.7); Supp + placebo 18.8 (3.7); monitoring 17.8 (2.6)39.4%SHLifetime64.8% (125/193)
Pluck 2012, United Kingdom63Cross-sectionalCommunity, inpatients87Schizophrenia onlySelf-harm- group: 40.1 (11.0); non-self- harm-group: 9.3 (12.7)90.%SHDeliberate Self- Harm Inventory (SHI)Lifetime68.0% (59/87)
Salim 2021, Lebanon71Cross-sectionalOutpatients93Schizophrenia only with command hallucinations55.9 (11.3)64.5%SHAggression scale (not clearly specified)23.7% (22/93)
Simms 2007, United Kingdom65Cross-sectionalInpatients33Schizophrenia onlySelf-harm group: 37.5 (8.4); non- self-harm group: 32.8 (14.7)66.7%SHLifetime51.5% (17/33)
Upthegrove 2010, United Kingdom66Cross-sectionalEarly Intervention Service (EIS)92Schizophrenia 70.0%; delusional disorder 4.3%; acute and transient psychotic disorder 8.7%; other non- organic psychotic disorder 3.3%; schizoaffective disorder 2.2%; mania with psychotic symptoms 7.6%; depressive disorder severe with psychotic symptoms 3.3%22.5 (4.8)75.0%SHSuicide attempt-self- injury interview II (SAS-II)Lifetime
12 mo following the first episode of psychosis
33.0% (30/92)
6.5% (6/92)
Verdolini 2017, Italy43Cross-sectionalInmates in Spoleto Prison25Schizophrenia spectrum disorder18 and older100.0%SHDeliberate Self- Harm Inventory (SHI)Lifetime32.0% (8/25)
Zimbrón 2013, United Kingdom67Cross-sectionalCameo Early Intervention Services60CHR-P 50.0%; FEP 50.0%CHR-P: 21.7 (4.2); FEP: 22.0 (4.2)60.0%SHLifetimeCHR-P: 40.0% (12/30); FEP: 23.3% (7/30)
Table 1.

Characteristics of all included studies.

Author Year, CountryDesignSample SourceNDiagnostic CompositionAge% MaleDefinition of Self-injurious BehaviorSelf-injury InstrumentSelf-injury Time PeriodPrevalence of Self-injurious Behavior
Barrowcliff 2010, United Kingdom46Cross-sectionalCommunity, inpatients29Schizophrenia or schizoaffective disorder with documented reports of auditory hallucinations in the previous month36.7 (11.8) (all individuals with command hallucinations)59.2% (all individuals with command hallucinations)Compliance with last self-harm command hallucinationCommand Hallucination Interview (CHI)31.0% (9/29)
Barrowclough 2010, United Kingdom47Randomized controlled trail (data from control arm)Patients with contact to NHS mental health trusts135Schizophrenia 81,7%; schizophreniform disorder 1.2%; psychosis NOS 8,9%; schizoaffective disorder 8.3% (at baseline)38.3 (10.0)84.0%SHBrief structured interview (not clearly specified)Past 12 mo11.9% (16/135)
Biswas 2006, India48Cross-sectionalOutpatients20Schizophrenia only31.5 (8.4)50.0%Self mutilatory/ injurious behavior, not otherwise specified (SH)Non-psychotic domain of Interview for the Retrospective Assessment of the Onset and Course of Schizophrenia and Other Psychoses (IRAOS)15.0% (3/20)
Dugré 2017, Canada37Cross-sectionalInpatients29Schizophrenia spectrum disorder30.28 (5.99) (all individuals in study)34.15% (all individuals in study)Compliance with self-harm command hallucinationsAuditory hallucinations schedule (AHS)Past 2 mo27.6% (8/29)
Grattan 2019, United States38Cross-sectionalOutpatients99Schizophrenia spectrum disorder12–3572.2% (all individuals in study)NSSIColumbia- Suicide Severity Scale (C-SSRS)Lifetime14.1% (14/99)
Güney 2020, Turkey49Cross-sectionalInpatients, outpatients, patienting contacting emergency psychiatric services165Schizophrenia 46.7% (77/165); psychosis NOS 35.8% (59/165); schizoaffective disorder 13.3% (22/165), substance- induced psychosis 4.2% (69/165)No NSSI: 20–65 (min–max) 40 (median); NSSI: 18–60 (min–max) 33 (median)72.2%NSSIInventory of Statements about Self- injury (ISAS)Lifetime43.6% (72/165)
Guo 2021, China70Cross-sectionalForensic Psychiatric Hospital389Schizophrenia 91.2% (372/408)44.3 (9.1)73.8%SHA standard questionnaire (not clearly specified)Lifetime7.7% (30/389)
Haining 2020, United Kingdom50Cross-sectionalYouth Mental Health Risk and Resilience study (YouR)145CHR-P: 89,7%; first episode of psychosis (FEP): 10,3%CHR-P: 21.6 (4.3); FEP: 23.7 (4.8)CHR-P: 6.0% FEP: 90.0%SH, suicide attempts includedComprehensive Assessment of At-Risk Mental States (CAARMS)Lifetime
Past month
CHR-P: 28.5% (38/130); FEP: 60.0% (9/15)
CHR-P: 5.4% (7/130; FEP: 20.0% (3/15)
Harvey 2008, United Kingdom51Cross-sectionalÆSOP (Aetiology and Ethnicity in Schizophrenia and Other Psychoses)496Schizophrenia spectrum disorder 72.2%; 27.8% mania or depressive psychosis30.8 (10.8)57.7%Attempted suicide or bodily harmPsychiatric and Personal History Schedule (PPHS)Lifetime
Between the onset of their psychotic symptoms and their first presentation to services
5.83% (29/496) (entire population)
9.21% (45/496) (schizophrenia spectrum disorder only)
Heslin 2016, United Kingdom52Prospective (including baseline cross-sectional data)ÆSOP (Aetiology and Ethnicity in Schizophrenia and Other Psychoses)163Schizophrenia only29 (median)64.2%SHWHO life chartLifetime12.9% (21/163)
Hunter 2009, United Kingdom53Prospective (including baseline cross-sectional data)NHS Health Boards in Scotland1015Schizophrenia 93.1%; schizotypal disorder, persistent delusional disorders, acute and transient psychotic disorders, and induced delusional disorder 2.0%; schizoaffective disorder 4.9%43 (11)70.0%SHHealth of the Nation Outcome Scales (HONOS)Past 12 mo8.9% (90/1015)
Jakhar 2015, India50Cross-sectionalInpatients270Schizophrenia only34.01 (9.883)64.8%SHRam Manohar Lohia Risk Assessment Interview31.4% (85/270)
Jarret 2016, United Kingdom54Cross-sectionalInmates in local London Prisons61CHR-P: 63.8%; FEP: 26.0%CHR-P: 27.5 (5.8); FEP: 27.7 (5.6)100.0%SHComprehensive Assessment of At-Risk Mental States (CAARMS)Lifetime
Past 12 mos
CHR-P: 25.0% (11/44); FEP: 32.0% (8/25)
CHR-P: 9.1% (4/44); FEP: 16.0% (4/25)
Koyanagi 2015, Japan44Cross-sectionalAdult Psychiatric Morbidity Survey 20077403Self-reported symptoms of mania/hypomania, thought control, paranoia, strange experiences, and auditory hallucinations16–34: 30.7%; 35–59: 42.9%; >60: 26.4%48.6% (all individuals)NSSILifetimeMania/hypomania 20.5%; paranoia 25.5%; strange experience 21.1%; auditory hallucination 32.5%
Laporte 2021, Sweden71Cross-sectionalForensic psychiatric patients70Schizophrenia spectrum and other psychotic disorders34.9 (10.7) (all individuals)86.7% (all individuals)SHInventory of Statements About Self- injury (ISAS)Lifetime46/70 (65.7%)
Lee 2012, China55Cross-sectionalTaiwan’s NHI program with a diagnosis of schizophrenia1655Self-reported schizophrenia only43.9 (12.2) (all individuals)59.2% (all individuals)SH10-item risk assessment inventory (not clearly specified)Past 12 mo1.9% (32/1655)
Lee 2004, Singapore56Cross-sectionalInpatients53Schizophrenia with command hallucinations in the past 6 mo only39.1 (9.7) (all individuals)45%Self-injurious acts in compliance with command hallucinationsSemi-structured questionnaire (not clearly specified)Past 6 mo11.3% (6/53)
Markovitz 1991, United States57Prospective (including baseline cross-sectional data)Outpatients14Schizotypal personality disorder only 28.6% (4/14); Schizotypal personality disorder and borderline personality disorder 71.4% (10/14)34.4 (6.9) (all individuals)40.9% (all individuals)Cutting onlyShort questionnaire (not clearly specified)Past 6 wkSchizotypal disorder: 50.0% (2/4)
Schizotypal disorder and borderline personality disorder: 70.0% (7/10)
Miles 2003, United Kingdom58Cross-sectionalCOMO randomized controlled trial16071.50% schizophrenia spectrum; 11.21 bipolar affective disorder; 17,29% other psychosis39 (11.1)83.2%SHLifetime29.0% (46/160)
Monahan 2017, United States41Prospective (including baseline cross-sectional data)MacArthur Violence Risk Assessment Study177Schizophrenia only18–40 (all individuals)57.6% (all individuals)NSSI and SHStructured interview (not clearly specified)2 mo prior to baseline
12 mo follow up
NSSI: 7.3% (13/177)
Deliberate self- harm: 15.8% (28/177)
Mork 2013, Norway42Cross-sectionalThematically Organized Psychosis (TOP) Study251Schizophrenia spectrum disorder30.1 (9.8)85.0%NSSI and SHQuestionnaire adapted from CASE-studyLifetimeNSSI: 29.9% (75/251); SH: 14.3% (36/251)
Mork 2012, Norway59Cross-sectionalTOP Study388Schizophrenia 76.2%; schizophreniform disorder 8.2%; schizoaffective disorder 15.5%31 (9.9)57.2%SHQuestionnaire adapted from CASE-studyLifetimeAt least one life-time episode of SH: 48.5% (188/388); Multiple episodes of SH: 28.1% (109/388)
Neeleman 1994, United States60Cross-sectionalOutpatients21Schizophrenia only45 (12.6)48.0%SH43.0% (9/21)
Nijman 1999, Netherlands61Cross-sectionalInpatients14Schizophrenia only37.5 (12.4) (all individuals)52.0% (all individuals)NSSILifetime57.1% (8/14)
Ose 2021, Norway62Cross-sectionalOutpatients1635Schizophrenia only37.0%NSSIPast month7.2% (117/1635)
Phillips 2009, Australia45Randomized controlled trail (including baseline cross-sectional data)PACE clinic193CHR-P onlyCogther + risp: 17.6 (3.0); CogTher + placebo 18.0 (2.7); Supp + placebo 18.8 (3.7); monitoring 17.8 (2.6)39.4%SHLifetime64.8% (125/193)
Pluck 2012, United Kingdom63Cross-sectionalCommunity, inpatients87Schizophrenia onlySelf-harm- group: 40.1 (11.0); non-self- harm-group: 9.3 (12.7)90.%SHDeliberate Self- Harm Inventory (SHI)Lifetime68.0% (59/87)
Salim 2021, Lebanon71Cross-sectionalOutpatients93Schizophrenia only with command hallucinations55.9 (11.3)64.5%SHAggression scale (not clearly specified)23.7% (22/93)
Simms 2007, United Kingdom65Cross-sectionalInpatients33Schizophrenia onlySelf-harm group: 37.5 (8.4); non- self-harm group: 32.8 (14.7)66.7%SHLifetime51.5% (17/33)
Upthegrove 2010, United Kingdom66Cross-sectionalEarly Intervention Service (EIS)92Schizophrenia 70.0%; delusional disorder 4.3%; acute and transient psychotic disorder 8.7%; other non- organic psychotic disorder 3.3%; schizoaffective disorder 2.2%; mania with psychotic symptoms 7.6%; depressive disorder severe with psychotic symptoms 3.3%22.5 (4.8)75.0%SHSuicide attempt-self- injury interview II (SAS-II)Lifetime
12 mo following the first episode of psychosis
33.0% (30/92)
6.5% (6/92)
Verdolini 2017, Italy43Cross-sectionalInmates in Spoleto Prison25Schizophrenia spectrum disorder18 and older100.0%SHDeliberate Self- Harm Inventory (SHI)Lifetime32.0% (8/25)
Zimbrón 2013, United Kingdom67Cross-sectionalCameo Early Intervention Services60CHR-P 50.0%; FEP 50.0%CHR-P: 21.7 (4.2); FEP: 22.0 (4.2)60.0%SHLifetimeCHR-P: 40.0% (12/30); FEP: 23.3% (7/30)
Author Year, CountryDesignSample SourceNDiagnostic CompositionAge% MaleDefinition of Self-injurious BehaviorSelf-injury InstrumentSelf-injury Time PeriodPrevalence of Self-injurious Behavior
Barrowcliff 2010, United Kingdom46Cross-sectionalCommunity, inpatients29Schizophrenia or schizoaffective disorder with documented reports of auditory hallucinations in the previous month36.7 (11.8) (all individuals with command hallucinations)59.2% (all individuals with command hallucinations)Compliance with last self-harm command hallucinationCommand Hallucination Interview (CHI)31.0% (9/29)
Barrowclough 2010, United Kingdom47Randomized controlled trail (data from control arm)Patients with contact to NHS mental health trusts135Schizophrenia 81,7%; schizophreniform disorder 1.2%; psychosis NOS 8,9%; schizoaffective disorder 8.3% (at baseline)38.3 (10.0)84.0%SHBrief structured interview (not clearly specified)Past 12 mo11.9% (16/135)
Biswas 2006, India48Cross-sectionalOutpatients20Schizophrenia only31.5 (8.4)50.0%Self mutilatory/ injurious behavior, not otherwise specified (SH)Non-psychotic domain of Interview for the Retrospective Assessment of the Onset and Course of Schizophrenia and Other Psychoses (IRAOS)15.0% (3/20)
Dugré 2017, Canada37Cross-sectionalInpatients29Schizophrenia spectrum disorder30.28 (5.99) (all individuals in study)34.15% (all individuals in study)Compliance with self-harm command hallucinationsAuditory hallucinations schedule (AHS)Past 2 mo27.6% (8/29)
Grattan 2019, United States38Cross-sectionalOutpatients99Schizophrenia spectrum disorder12–3572.2% (all individuals in study)NSSIColumbia- Suicide Severity Scale (C-SSRS)Lifetime14.1% (14/99)
Güney 2020, Turkey49Cross-sectionalInpatients, outpatients, patienting contacting emergency psychiatric services165Schizophrenia 46.7% (77/165); psychosis NOS 35.8% (59/165); schizoaffective disorder 13.3% (22/165), substance- induced psychosis 4.2% (69/165)No NSSI: 20–65 (min–max) 40 (median); NSSI: 18–60 (min–max) 33 (median)72.2%NSSIInventory of Statements about Self- injury (ISAS)Lifetime43.6% (72/165)
Guo 2021, China70Cross-sectionalForensic Psychiatric Hospital389Schizophrenia 91.2% (372/408)44.3 (9.1)73.8%SHA standard questionnaire (not clearly specified)Lifetime7.7% (30/389)
Haining 2020, United Kingdom50Cross-sectionalYouth Mental Health Risk and Resilience study (YouR)145CHR-P: 89,7%; first episode of psychosis (FEP): 10,3%CHR-P: 21.6 (4.3); FEP: 23.7 (4.8)CHR-P: 6.0% FEP: 90.0%SH, suicide attempts includedComprehensive Assessment of At-Risk Mental States (CAARMS)Lifetime
Past month
CHR-P: 28.5% (38/130); FEP: 60.0% (9/15)
CHR-P: 5.4% (7/130; FEP: 20.0% (3/15)
Harvey 2008, United Kingdom51Cross-sectionalÆSOP (Aetiology and Ethnicity in Schizophrenia and Other Psychoses)496Schizophrenia spectrum disorder 72.2%; 27.8% mania or depressive psychosis30.8 (10.8)57.7%Attempted suicide or bodily harmPsychiatric and Personal History Schedule (PPHS)Lifetime
Between the onset of their psychotic symptoms and their first presentation to services
5.83% (29/496) (entire population)
9.21% (45/496) (schizophrenia spectrum disorder only)
Heslin 2016, United Kingdom52Prospective (including baseline cross-sectional data)ÆSOP (Aetiology and Ethnicity in Schizophrenia and Other Psychoses)163Schizophrenia only29 (median)64.2%SHWHO life chartLifetime12.9% (21/163)
Hunter 2009, United Kingdom53Prospective (including baseline cross-sectional data)NHS Health Boards in Scotland1015Schizophrenia 93.1%; schizotypal disorder, persistent delusional disorders, acute and transient psychotic disorders, and induced delusional disorder 2.0%; schizoaffective disorder 4.9%43 (11)70.0%SHHealth of the Nation Outcome Scales (HONOS)Past 12 mo8.9% (90/1015)
Jakhar 2015, India50Cross-sectionalInpatients270Schizophrenia only34.01 (9.883)64.8%SHRam Manohar Lohia Risk Assessment Interview31.4% (85/270)
Jarret 2016, United Kingdom54Cross-sectionalInmates in local London Prisons61CHR-P: 63.8%; FEP: 26.0%CHR-P: 27.5 (5.8); FEP: 27.7 (5.6)100.0%SHComprehensive Assessment of At-Risk Mental States (CAARMS)Lifetime
Past 12 mos
CHR-P: 25.0% (11/44); FEP: 32.0% (8/25)
CHR-P: 9.1% (4/44); FEP: 16.0% (4/25)
Koyanagi 2015, Japan44Cross-sectionalAdult Psychiatric Morbidity Survey 20077403Self-reported symptoms of mania/hypomania, thought control, paranoia, strange experiences, and auditory hallucinations16–34: 30.7%; 35–59: 42.9%; >60: 26.4%48.6% (all individuals)NSSILifetimeMania/hypomania 20.5%; paranoia 25.5%; strange experience 21.1%; auditory hallucination 32.5%
Laporte 2021, Sweden71Cross-sectionalForensic psychiatric patients70Schizophrenia spectrum and other psychotic disorders34.9 (10.7) (all individuals)86.7% (all individuals)SHInventory of Statements About Self- injury (ISAS)Lifetime46/70 (65.7%)
Lee 2012, China55Cross-sectionalTaiwan’s NHI program with a diagnosis of schizophrenia1655Self-reported schizophrenia only43.9 (12.2) (all individuals)59.2% (all individuals)SH10-item risk assessment inventory (not clearly specified)Past 12 mo1.9% (32/1655)
Lee 2004, Singapore56Cross-sectionalInpatients53Schizophrenia with command hallucinations in the past 6 mo only39.1 (9.7) (all individuals)45%Self-injurious acts in compliance with command hallucinationsSemi-structured questionnaire (not clearly specified)Past 6 mo11.3% (6/53)
Markovitz 1991, United States57Prospective (including baseline cross-sectional data)Outpatients14Schizotypal personality disorder only 28.6% (4/14); Schizotypal personality disorder and borderline personality disorder 71.4% (10/14)34.4 (6.9) (all individuals)40.9% (all individuals)Cutting onlyShort questionnaire (not clearly specified)Past 6 wkSchizotypal disorder: 50.0% (2/4)
Schizotypal disorder and borderline personality disorder: 70.0% (7/10)
Miles 2003, United Kingdom58Cross-sectionalCOMO randomized controlled trial16071.50% schizophrenia spectrum; 11.21 bipolar affective disorder; 17,29% other psychosis39 (11.1)83.2%SHLifetime29.0% (46/160)
Monahan 2017, United States41Prospective (including baseline cross-sectional data)MacArthur Violence Risk Assessment Study177Schizophrenia only18–40 (all individuals)57.6% (all individuals)NSSI and SHStructured interview (not clearly specified)2 mo prior to baseline
12 mo follow up
NSSI: 7.3% (13/177)
Deliberate self- harm: 15.8% (28/177)
Mork 2013, Norway42Cross-sectionalThematically Organized Psychosis (TOP) Study251Schizophrenia spectrum disorder30.1 (9.8)85.0%NSSI and SHQuestionnaire adapted from CASE-studyLifetimeNSSI: 29.9% (75/251); SH: 14.3% (36/251)
Mork 2012, Norway59Cross-sectionalTOP Study388Schizophrenia 76.2%; schizophreniform disorder 8.2%; schizoaffective disorder 15.5%31 (9.9)57.2%SHQuestionnaire adapted from CASE-studyLifetimeAt least one life-time episode of SH: 48.5% (188/388); Multiple episodes of SH: 28.1% (109/388)
Neeleman 1994, United States60Cross-sectionalOutpatients21Schizophrenia only45 (12.6)48.0%SH43.0% (9/21)
Nijman 1999, Netherlands61Cross-sectionalInpatients14Schizophrenia only37.5 (12.4) (all individuals)52.0% (all individuals)NSSILifetime57.1% (8/14)
Ose 2021, Norway62Cross-sectionalOutpatients1635Schizophrenia only37.0%NSSIPast month7.2% (117/1635)
Phillips 2009, Australia45Randomized controlled trail (including baseline cross-sectional data)PACE clinic193CHR-P onlyCogther + risp: 17.6 (3.0); CogTher + placebo 18.0 (2.7); Supp + placebo 18.8 (3.7); monitoring 17.8 (2.6)39.4%SHLifetime64.8% (125/193)
Pluck 2012, United Kingdom63Cross-sectionalCommunity, inpatients87Schizophrenia onlySelf-harm- group: 40.1 (11.0); non-self- harm-group: 9.3 (12.7)90.%SHDeliberate Self- Harm Inventory (SHI)Lifetime68.0% (59/87)
Salim 2021, Lebanon71Cross-sectionalOutpatients93Schizophrenia only with command hallucinations55.9 (11.3)64.5%SHAggression scale (not clearly specified)23.7% (22/93)
Simms 2007, United Kingdom65Cross-sectionalInpatients33Schizophrenia onlySelf-harm group: 37.5 (8.4); non- self-harm group: 32.8 (14.7)66.7%SHLifetime51.5% (17/33)
Upthegrove 2010, United Kingdom66Cross-sectionalEarly Intervention Service (EIS)92Schizophrenia 70.0%; delusional disorder 4.3%; acute and transient psychotic disorder 8.7%; other non- organic psychotic disorder 3.3%; schizoaffective disorder 2.2%; mania with psychotic symptoms 7.6%; depressive disorder severe with psychotic symptoms 3.3%22.5 (4.8)75.0%SHSuicide attempt-self- injury interview II (SAS-II)Lifetime
12 mo following the first episode of psychosis
33.0% (30/92)
6.5% (6/92)
Verdolini 2017, Italy43Cross-sectionalInmates in Spoleto Prison25Schizophrenia spectrum disorder18 and older100.0%SHDeliberate Self- Harm Inventory (SHI)Lifetime32.0% (8/25)
Zimbrón 2013, United Kingdom67Cross-sectionalCameo Early Intervention Services60CHR-P 50.0%; FEP 50.0%CHR-P: 21.7 (4.2); FEP: 22.0 (4.2)60.0%SHLifetimeCHR-P: 40.0% (12/30); FEP: 23.3% (7/30)

The lifetime prevalence of SH in individuals with SSD ranged from 7.7% to 68.0%, whereas the lifetime prevalence of NSSI ranged from 14.1% to 57.1%. The 12-month prevalence of SH ranged from 1.9% to 11.9%. In individuals at CHR-P the lifetime prevalence of SH ranged from 25.0% to 64.8%.

Risk of Bias Assessment

Bias assessment of all studies is displayed in Table 2. Of the included studies, none were without remarks on the Joana Briggs Institute Critical Appraisal Checklist for Prevalence Studies. Several studies had issues regarding recruitment (59.4%) and insufficient sample sizes (78.1%) due to the use of convenience sampling and small study sizes (questions 2 and 3). A principal issue for several studies was the lack of valid (46.9%) and reliable (59.4%) reporting of self-injurious behavior (questions 6 and 7).

Table 2.

Overview of the risk of bias assessment for all included studies.

1) Was the Sample Frame Appropriate to Address the Target Population?2) Were Study Participants Recruited in an Appropriate Way?3) Was the Sample Size Adequate?4) Were the Study Subjects and Setting Described in Detail?5) Was Data Analysis Conducted With Sfficient Coverage of the Identified Sample?6) Were Valid Methods Used for the Identification of the Condition?7) Was the ondition Measured in a Standard, Reliable Way for All Participants?8) Was There Appropriate Statistical Analysis?9) Was the Response Rate Adequate, and if Not, was the Low Response Rate Managed Appropriately?
Barrowcliff 201046YesNoNoYesUnclearYesNoYesUnclear
Barrowclough 201047YesNoNoYesNot app.NoNoYesYes
Biswas 200548YesNoNoYesNot appYesNoNoNot app
Dugré 201737YesNoNoYesNot appYesNoYesNot app
Grattan 201938YesNoNoYesNot appYesYesYesNot app
Güney 202049YesNoNoYesNot appYesNoYesNot app
Guo 202170YesNoYesYesYesYesUnclearYesYes
Haining 202050YesNoNoYesNot appYesYesYesNot app
Harvey 200851YesYesYesYesNot appNoNoYesNoa
Heslin 201652YesNoNoYesNot appYesNoYesNoa
Hunter 200953YesYesYesYesNot appYesYesYesNot app
Jakhar 201550YesNoNoYesNot appYesNoNoNot app
Jarrett 201654YesYesNoYesNot appNoNoYesYes
Koyanagi 201544YesYesYesYesNot appNoYesYesNot app
Laporte 202171YesNoNoYesNoYesYesYesNo
Lee 201255YesYesYesYesYesNoYesYesYes
Lee 200456YesYesNoYesNot appNoNoYesNot app
Markovitz 199157YesNoNoNoNot appNoNoYesNot app
Miles 200358YesYesNoYesNot appNoNoYesYes
Monahan 201741YesNoNoNoNot appYesNoYesNot app
Mork 201342YesNoNoYes Not appNoYesYesNot app
Mork 201259YesNoYesYes Not appNoYesYes Not app
Neeleman 199460Not clearNoNoYesNot appNoNoNo Not app
Nijman 199961YesNoNoYesNot appNoNoYesNot app
Ose 202062YesYesYesYesUnclearNoNoNoUnclear
Phillips 200945YesNoNoYesNot appYesNoYesNot app
Pluck 201363YesNoNoYesNot appYesYesYesNot app
Salim 202171YesYesNoYesNoNoUnclearYesYes
Simms 200765YesYesNoYesNot appNoYesYesNot app
Upthegrove 201066YesYesNoYesUnclearYesYesYesYes
Verdolini 201743YesYesNoYesUnclearYesYesYesUnclear
Zimbrón 201367YesYesNoYesNot appYesNoYes Not app
1) Was the Sample Frame Appropriate to Address the Target Population?2) Were Study Participants Recruited in an Appropriate Way?3) Was the Sample Size Adequate?4) Were the Study Subjects and Setting Described in Detail?5) Was Data Analysis Conducted With Sfficient Coverage of the Identified Sample?6) Were Valid Methods Used for the Identification of the Condition?7) Was the ondition Measured in a Standard, Reliable Way for All Participants?8) Was There Appropriate Statistical Analysis?9) Was the Response Rate Adequate, and if Not, was the Low Response Rate Managed Appropriately?
Barrowcliff 201046YesNoNoYesUnclearYesNoYesUnclear
Barrowclough 201047YesNoNoYesNot app.NoNoYesYes
Biswas 200548YesNoNoYesNot appYesNoNoNot app
Dugré 201737YesNoNoYesNot appYesNoYesNot app
Grattan 201938YesNoNoYesNot appYesYesYesNot app
Güney 202049YesNoNoYesNot appYesNoYesNot app
Guo 202170YesNoYesYesYesYesUnclearYesYes
Haining 202050YesNoNoYesNot appYesYesYesNot app
Harvey 200851YesYesYesYesNot appNoNoYesNoa
Heslin 201652YesNoNoYesNot appYesNoYesNoa
Hunter 200953YesYesYesYesNot appYesYesYesNot app
Jakhar 201550YesNoNoYesNot appYesNoNoNot app
Jarrett 201654YesYesNoYesNot appNoNoYesYes
Koyanagi 201544YesYesYesYesNot appNoYesYesNot app
Laporte 202171YesNoNoYesNoYesYesYesNo
Lee 201255YesYesYesYesYesNoYesYesYes
Lee 200456YesYesNoYesNot appNoNoYesNot app
Markovitz 199157YesNoNoNoNot appNoNoYesNot app
Miles 200358YesYesNoYesNot appNoNoYesYes
Monahan 201741YesNoNoNoNot appYesNoYesNot app
Mork 201342YesNoNoYes Not appNoYesYesNot app
Mork 201259YesNoYesYes Not appNoYesYes Not app
Neeleman 199460Not clearNoNoYesNot appNoNoNo Not app
Nijman 199961YesNoNoYesNot appNoNoYesNot app
Ose 202062YesYesYesYesUnclearNoNoNoUnclear
Phillips 200945YesNoNoYesNot appYesNoYesNot app
Pluck 201363YesNoNoYesNot appYesYesYesNot app
Salim 202171YesYesNoYesNoNoUnclearYesYes
Simms 200765YesYesNoYesNot appNoYesYesNot app
Upthegrove 201066YesYesNoYesUnclearYesYesYesYes
Verdolini 201743YesYesNoYesUnclearYesYesYesUnclear
Zimbrón 201367YesYesNoYesNot appYesNoYes Not app

aNo evidence of systematic differences by age, sex, ethnicity, duration of untreated psychosis, baseline employment, baseline diagnosis, mode of initial contact with mental health services or study center between participants and individuals lost to follow-up.

Table 2.

Overview of the risk of bias assessment for all included studies.

1) Was the Sample Frame Appropriate to Address the Target Population?2) Were Study Participants Recruited in an Appropriate Way?3) Was the Sample Size Adequate?4) Were the Study Subjects and Setting Described in Detail?5) Was Data Analysis Conducted With Sfficient Coverage of the Identified Sample?6) Were Valid Methods Used for the Identification of the Condition?7) Was the ondition Measured in a Standard, Reliable Way for All Participants?8) Was There Appropriate Statistical Analysis?9) Was the Response Rate Adequate, and if Not, was the Low Response Rate Managed Appropriately?
Barrowcliff 201046YesNoNoYesUnclearYesNoYesUnclear
Barrowclough 201047YesNoNoYesNot app.NoNoYesYes
Biswas 200548YesNoNoYesNot appYesNoNoNot app
Dugré 201737YesNoNoYesNot appYesNoYesNot app
Grattan 201938YesNoNoYesNot appYesYesYesNot app
Güney 202049YesNoNoYesNot appYesNoYesNot app
Guo 202170YesNoYesYesYesYesUnclearYesYes
Haining 202050YesNoNoYesNot appYesYesYesNot app
Harvey 200851YesYesYesYesNot appNoNoYesNoa
Heslin 201652YesNoNoYesNot appYesNoYesNoa
Hunter 200953YesYesYesYesNot appYesYesYesNot app
Jakhar 201550YesNoNoYesNot appYesNoNoNot app
Jarrett 201654YesYesNoYesNot appNoNoYesYes
Koyanagi 201544YesYesYesYesNot appNoYesYesNot app
Laporte 202171YesNoNoYesNoYesYesYesNo
Lee 201255YesYesYesYesYesNoYesYesYes
Lee 200456YesYesNoYesNot appNoNoYesNot app
Markovitz 199157YesNoNoNoNot appNoNoYesNot app
Miles 200358YesYesNoYesNot appNoNoYesYes
Monahan 201741YesNoNoNoNot appYesNoYesNot app
Mork 201342YesNoNoYes Not appNoYesYesNot app
Mork 201259YesNoYesYes Not appNoYesYes Not app
Neeleman 199460Not clearNoNoYesNot appNoNoNo Not app
Nijman 199961YesNoNoYesNot appNoNoYesNot app
Ose 202062YesYesYesYesUnclearNoNoNoUnclear
Phillips 200945YesNoNoYesNot appYesNoYesNot app
Pluck 201363YesNoNoYesNot appYesYesYesNot app
Salim 202171YesYesNoYesNoNoUnclearYesYes
Simms 200765YesYesNoYesNot appNoYesYesNot app
Upthegrove 201066YesYesNoYesUnclearYesYesYesYes
Verdolini 201743YesYesNoYesUnclearYesYesYesUnclear
Zimbrón 201367YesYesNoYesNot appYesNoYes Not app
1) Was the Sample Frame Appropriate to Address the Target Population?2) Were Study Participants Recruited in an Appropriate Way?3) Was the Sample Size Adequate?4) Were the Study Subjects and Setting Described in Detail?5) Was Data Analysis Conducted With Sfficient Coverage of the Identified Sample?6) Were Valid Methods Used for the Identification of the Condition?7) Was the ondition Measured in a Standard, Reliable Way for All Participants?8) Was There Appropriate Statistical Analysis?9) Was the Response Rate Adequate, and if Not, was the Low Response Rate Managed Appropriately?
Barrowcliff 201046YesNoNoYesUnclearYesNoYesUnclear
Barrowclough 201047YesNoNoYesNot app.NoNoYesYes
Biswas 200548YesNoNoYesNot appYesNoNoNot app
Dugré 201737YesNoNoYesNot appYesNoYesNot app
Grattan 201938YesNoNoYesNot appYesYesYesNot app
Güney 202049YesNoNoYesNot appYesNoYesNot app
Guo 202170YesNoYesYesYesYesUnclearYesYes
Haining 202050YesNoNoYesNot appYesYesYesNot app
Harvey 200851YesYesYesYesNot appNoNoYesNoa
Heslin 201652YesNoNoYesNot appYesNoYesNoa
Hunter 200953YesYesYesYesNot appYesYesYesNot app
Jakhar 201550YesNoNoYesNot appYesNoNoNot app
Jarrett 201654YesYesNoYesNot appNoNoYesYes
Koyanagi 201544YesYesYesYesNot appNoYesYesNot app
Laporte 202171YesNoNoYesNoYesYesYesNo
Lee 201255YesYesYesYesYesNoYesYesYes
Lee 200456YesYesNoYesNot appNoNoYesNot app
Markovitz 199157YesNoNoNoNot appNoNoYesNot app
Miles 200358YesYesNoYesNot appNoNoYesYes
Monahan 201741YesNoNoNoNot appYesNoYesNot app
Mork 201342YesNoNoYes Not appNoYesYesNot app
Mork 201259YesNoYesYes Not appNoYesYes Not app
Neeleman 199460Not clearNoNoYesNot appNoNoNo Not app
Nijman 199961YesNoNoYesNot appNoNoYesNot app
Ose 202062YesYesYesYesUnclearNoNoNoUnclear
Phillips 200945YesNoNoYesNot appYesNoYesNot app
Pluck 201363YesNoNoYesNot appYesYesYesNot app
Salim 202171YesYesNoYesNoNoUnclearYesYes
Simms 200765YesYesNoYesNot appNoYesYesNot app
Upthegrove 201066YesYesNoYesUnclearYesYesYesYes
Verdolini 201743YesYesNoYesUnclearYesYesYesUnclear
Zimbrón 201367YesYesNoYesNot appYesNoYes Not app

aNo evidence of systematic differences by age, sex, ethnicity, duration of untreated psychosis, baseline employment, baseline diagnosis, mode of initial contact with mental health services or study center between participants and individuals lost to follow-up.

Synthesis of Data

Meta-analysis was conducted on the lifetime prevalence of any self-injurious behavior. Separate meta-analyses were conducted for the group with an SSD and the group at CHR-P. Due to lack of studies and heterogeneity, no meta-analysis was conducted for self-injurious behavior in relation to SH command hallucinations.

Twenty studies with a total sample size of 2822 were included in the main meta-analysis of self-injurious behavior (including both NSSI and SH) in individuals with an SSD. The pooled prevalence of all self-injurious behavior was 31.0% (95% CI: 22.1%; 41.6%) (figure 2).

Forest plot of the lifetime prevalence of self-injurious behavior in individuals with a schizophrenia spectrum disorder (SSD). The overall pooled lifetime prevalence of self-injurious behavior regardless of suicidal intent is shown at the bottom of the forest plot marked with a diamond. All prevalence are shown as proportions.
Fig. 2.

Forest plot of the lifetime prevalence of self-injurious behavior in individuals with a schizophrenia spectrum disorder (SSD). The overall pooled lifetime prevalence of self-injurious behavior regardless of suicidal intent is shown at the bottom of the forest plot marked with a diamond. All prevalence are shown as proportions.

The estimate showed a high and statistically significant degree of heterogeneity (I2 = 94.9% [95% CI: 93.3%; 96.1%] P = <.0001), which was further supported by the outlier analysis that found 6 outlier-studies.52,53,60,64,70,71 Exclusion of outlying studies, however, did not markedly change the pooled prevalence estimate (33.0% [95% CI: 26.4%; 40.3%]), but did lower the degree of heterogeneity (I2 = 69.8% [95% CI: 47.6%; 82.5%], P = <.0001). When pooling data using the inverse variance method with the Freeman–Tukey transformation, pooled prevalence of all self-injurious behavior was 32.5% (95% CI: 23.6%; 42.1%), which did not substantially differ from the generalized linear mixed model method. A subgroup analysis was conducted for the lifetime prevalence of SH and NSSI, showing a pooled prevalence of 30.5% ([95% CI: 20.2%; 43.2%]; I2 = 94.6%) and 32.6% ([95% CI: 13.3%; 60.4%]; I2 = 90.3%), respectively. Both subgroup analyses showed a high degree of heterogeneity. There was no statistically significant difference between the 2 subgroups of self-injurious behavior (Q = 0.05; d.f. = 1, P = .83). All studies from the primary meta-analysis were included in a funnel plot, see supplementary material 5, which showed some visual asymmetry. Eggers’ test, however, did not indicate the presence of statistically significant funnel plot asymmetry (intercept: −0.917; 95% CI: −5.28; 3.45, P = .69).

Four studies with a total sample size of 397 were included in the meta-analysis of self-injurious behavior (including both NSSI and SH) in individuals at CHR-P. The pooled lifetime prevalence of self-injurious behavior in individuals at CHR-P was 39.7% (95% CI: 17.5%; 70.0%, I2 = 93.7%, P = <.0001). Results are graphically displayed in figure 3. The I2-value indicated a high degree of heterogeneity; however, no outliers were identified in the outlier analysis. When pooling data using the inverse variance method with the Freeman–Tukey transformation, pooled prevalence of all self-injurious behavior was 40.0% (95% CI: 13.9%; 69.5%), which did not substantially differ from the generalized linear mixed model method. The generated funnel plot showed no sign of asymmetry and thus no indication of publication bias. Egger’s test was not conducted due to a lack of sufficient statistical power to detect bias.

Forest plot of the lifetime prevalence of self-injurious behavior in individuals at clinical high risk of psychosis. All prevalence are shown as proportions.
Fig. 3.

Forest plot of the lifetime prevalence of self-injurious behavior in individuals at clinical high risk of psychosis. All prevalence are shown as proportions.

Characteristics of Self-injurious Behavior in SSD

Güney et al50 found that the most common forms of NSSI were cutting (37.5%), hair pulling (11.1%) and scratching (11.1%). 23.8% of the self-harming group used multiple forms of NSSI. Intrapersonal functions of self-injurious behavior (total score for intrapersonal functions in Inventory of Statements About Self-injury [ISAS]72: 7.11 [3.963]), eg, affect regulation, self-punishment, and marking distress, were found to be more common than social functions of self-injurious behavior (total score for social functions in ISAS: 6.33 [5.720]), eg, revenge, self-care, and sensation seeking. Mork et al42 found that in 96% of individuals the last recent incident of NSSI had little or no risk of death, most NSSI-acts been planned for less than 1 hour (65%), and that the most common method was cutting (78%). Harvey et al52 investigated SH, finding that individuals engaged in self-injurious behavior had primarily taken an overdose (29%) or engaged in cutting (30%). Three of the included studies examined SH command hallucinations, finding a compliance rate of 11.3%–31.0%.37,47,57

Discussion

This study presents a meta-analysis on the lifetime prevalence of self-injurious behavior in individuals with an SSD, and is, to the best of our knowledge, the first meta-analysis on the prevalence of NSSI in this patient group. The meta-analysis showed a pooled lifetime prevalence of self-injurious behavior irrespective of suicidal intent in the SSD group of 31.0% (95% CI: 22.1%; 41.6%), which was corrected to 33.0% (95% CI: 26.4%; 40.3%), upon exclusion of outlying studies. In studies reporting NSSI only there was a pooled prevalence of self-injurious behavior of 32.6% ((95% CI: 13.3%; 60.4%); I2 = 90.3%), whereas in studies reporting SH excluding NSSI-only studies there are a pooled prevalence of 30.5% ((95% CI: 20.2%; 43.2%); I2 = 94.6%). The 2 subgroups were not statistically significantly different. The pooled prevalence of self-injurious behavior regardless of suicidal intent was 39.7% (95% CI: 17.5%; 70.0%, I2 = 93.7%, P = <.0001) for individuals at CHR-P.

The pooled prevalence estimates for the group with an SSD and at CHR-P both displayed some degree of heterogeneity. The generated funnel plot for the group with an SSD showed a significant degree of visual asymmetry, suggesting a leftward skew of data. Egger’s test was, however, non-significant and did not suggest publication bias. Studies with small or non-significant findings are more often subject to delayed publication than studies showing large or significant results.73,74 Though possible, it is therefore unlikely that the observed asymmetry was due to publication bias favoring an underestimation of the true prevalence of self-injurious behavior. A funnel plot may also appear asymmetric due to heterogeneity in data, which may derive from the lack of reliable and validated tools for quantification of self-injurious behavior or the inclusion of mixed diagnostic populations in the meta-analysis, as self-injurious behavior previously has shown an association to a range of disorders including depression, anxiety, borderline personality disorder, and post-traumatic stress disorder.16,75 Likewise, only English-language articles were included in this review, favoring studies conducted in Western countries, and possibly introducing bias. The I2-statitic for the CHR-P group showed a high degree of heterogeneity, which was not reflected in the generated funnel plot, and consequently may be a result of poor statistical power.

The results of the current meta-analysis slightly deviated from estimates found in similar meta-analyses. In their meta-analysis on the prevalence of SH prior to treatment of psychosis, Challis et al22 found a pooled prevalence of 18.4% (95% CI: 14.4; 23.3). The current study’s pooled prevalence may be significantly higher due to multiple factors. The interest in lifetime SH prolongs the period-of-interest, plausibly resulting in a higher prevalence of SH. As suggested by Upthegrove et al,66 the incidence of self-injurious behavior may be high during the period of early symptomatology. Exclusion of the early-treatment period in the prevalence measure may falsely curtail SH-prevalence. The inclusion of chart reviews may underestimate the true prevalence of self-injurious behavior. Taylor et al21 found a pooled lifetime prevalence of SH of 49.38% (95% CI 33.08–65.74) in individuals at CHR-P, which did not significantly differ from our estimate. In both studies, 4 studies were included in the meta-analysis. Taylor et al included 4 studies of which 2 studies46,67 were also included in the current meta-analysis. Taylor et al included chart review in their meta-analysis and utilized a Freeman–Tukey transformation rather than the logit transformation in their meta-analysis.

Limitations

First, given the substantial heterogeneity in the point estimates of the meta-analysis, the findings in the current review should be interpreted with caution. Variance in definition and quantification method of self-injurious behavior may have contributed to heterogeneity in this review. As indicated by the risk of bias assessment, over half of the included studies had concerns with the validity and/or reliability of their quantification of self-injurious behavior, which may massively contribute to heterogeneity. Studies support that assessment methods of self-injurious behavior largely influence prevalence measures, finding a higher prevalence estimates when employing checklists rather than single items questions.16 Consequently, not only the definition of self-injurious behavior, but also the manner in which it is verified largely impacts the recorded prevalence, plausibly leading to heterogeneity. Also, multiple studies support NSSI and suicide attempts as distinct phenomena,15,16 still it has also been argued that suicidal intent should be regarded as a spectrum with no easily identifiable cut-offs.76 Addressing self-injurious behavior through a strict NSSI-definition may underestimate the true prevalence of self-injurious behavior, eg, self-poisoning can by definition not be viewed as NSSI, however, may often occur without suicidal intent.17,77 Conversely, solely applying a broad definition of SH will inevitably include actions with clear suicidal intent. Only studies with a clear definition of self-injurious behavior without suicidal intent were placed into the NSSI-category in the meta-analysis. Presumably, this underestimated the true prevalence of NSSI, as some studies may use SH-terminology, when actually employing a NSSI-definition.

Second, heterogeneity in the current review may also have arisen due to differences in sample composition and cultural differences, which may have been accentuated by the use of convenience sampling in many studies (see Table 2). As displayed in Table 1, there was a significant variance in the origin of the samples in the included studies, ie, outpatient and inpatient samples, which may present a proxy measure for both the severity and level of chronicity of SSD and thus the prevalence of self-injurious behavior. Likewise, the distribution of gender differs from study to study. NSSI is assumed more common among women than men and is sometimes solely referred to as self-cutting, which is more common with women than with men.78 Characteristics, functions, and gender-specific patterns of self-injurious behavior differ between Western and Non-western countries.79 Therefore the inclusion of studies from both Western and Non-western countries may have contributed to the heterogeneity. Although several causes for heterogeneity have been scrutinized in this review, a comprehensive investigation of the sources of this heterogeneity should be conducted in future studies, eg, via subgroup analyses. Subgroup analysis was not possible in this study due to scarcity of data.

Third, the current study was carried out using a broad search of electronic databases with the purpose of conducting an extensive literature search, however, studies with data concerning self-injurious behavior obtained solely from chart review-data were excluded. This resulted in the exclusion of many articles that had been included in previous reviews,21,22 and may have omitted relevant articles and weakened statistical power. The approach was, however, chosen to increase homogeneity in the dataset, as it was deemed that chart reviews inevitably would underestimate the true prevalence of self-injurious behavior.

Fourth, contradictory recommendations of the transformations of proportions in meta-analysis have been published. Barendregt et al80 recommended the use of the Freeman–Tukey transformation (arcsine square root transformation) prior to pooling of data to adjust for variance instability. Schwarzer et al81 and Warton & Hui82 found misleading results with the back-transformation of the Freeman–Tukey transformation and advised the use of a generalized linear mixed model with the logit transformation instead. The current lack of consensus on a golden standard for statistical methods in prevalence meta-analysis challenges the cogency of the current estimates, however, no significant differences in the pooled prevalence estimates were seen when using the Freeman–Tukey transformation.

Fifth, only 3 of the included studies presented data on methods, severity, and functions of self-injurious behavior, displaying a possible gap in the current knowledge. Güney et al50 was the only study that examined the functions of self-injurious behavior using ISAS,72 which does not examine functions of SH of a psychotic nature, eg, SH command hallucinations. Included studies examining command hallucinations suggest that SH command hallucinations are a frequent cause of self-injurious behavior in individuals with psychosis experiencing command hallucinations. The absence of self-injury questionnaires relevant to individuals with psychotic disorders may disregard facets of self-injurious behavior concerning methods and functions.

Conclusions

The meta-analysis found a pooled lifetime prevalence of self-injurious behavior irrespective of suicidal intent of 31.0% (95% CI: 22.1%; 41.6%). in individuals with an SSD and 39.7% (95% CI: 17.5%; 70.0%) in individuals at CHR-P. Data on methods, severity, and functions of self-injurious behavior in individuals with SSD was scarce, indicating a possible gap in the current knowledge. However, the most commonly observed method was cutting and incidents overwhelmingly exhibited a low level of lethality. Intrapersonal functions were more common than social functions, however, SH command hallucinations may be an overlooked cause due to the lack of self-injury instruments relevant to individuals with schizophrenia spectrum disorder. Larger studies regarding methods, severity, and functions of self-injurious behavior in individuals with psychosis are needed.

Acknowledgment

We thank Anders Helles Carlsen for his assistance with statistical work in R studio. The authors have declared that there are no conflicts of interest in relation to the subject of this study.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

References

1.

Mueser
KT
,
McGurk
SR
.
Schizophrenia
.
Lancet.
2004
;
363
(
9426
):
2063
2072
.

2.

Saha
S
,
Chant
D
,
Welham
J
,
McGrath
J
.
A systematic review of the prevalence of schizophrenia
.
PLoS Med.
2005
;
2
(
5
):
e141
.

3.

Pedersen
CB
,
Mors
O
,
Bertelsen
A
, et al.
A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders
.
JAMA Psychiatry.
2014
;
71
(
5
):
573
581
.

4.

Picchioni
MM
,
Murray
RM
.
Schizophrenia
.
BMJ.
2007
;
335
(
7610
):
91
95
.

5.

Cloutier
M
,
Aigbogun
MS
,
Guerin
A
, et al.
The economic burden of schizophrenia in the United States in 2013
.
J Clin Psychiatry.
2016
;
77
(
6
):
764
771
.

6.

Klonsky
ED
.
Non-suicidal self-injury in United States adults: prevalence, sociodemographics, topography and functions
.
Psychol Med.
2011
;
41
(
9
):
1981
1986
.

7.

Muehlenkamp
JJ
,
Claes
L
,
Havertape
L
,
Plener
PL
.
International prevalence of adolescent non-suicidal self-injury and deliberate self-harm
.
Child Adolesc Psychiatry Ment Health.
2012
;
6
:
10
.

8.

Kerr
PL
,
Muehlenkamp
JJ
,
Turner
JM
.
Nonsuicidal self-injury: a review of current research for family medicine and primary care physicians
.
J Am Board Fam Med.
2010
;
23
(
2
):
240
259
.

9.

Kiekens
G
,
Hasking
P
,
Boyes
M
, et al.
The associations between non-suicidal self-injury and first onset suicidal thoughts and behaviors
.
J Affect Disord.
2018
;
239
:
171
179
.

10.

Victor
SE
,
Klonsky
ED
.
Correlates of suicide attempts among self-injurers: a meta-analysis
.
Clin Psychol Rev
.
2014
;
34
(
4
):
282
297
.

11.

Whitlock
J
,
Muehlenkamp
J
,
Eckenrode
J
, et al.
Nonsuicidal self-injury as a gateway to suicide in young adults
.
J Adolesc Health.
2013
;
52
(
4
):
486
492
.

12.

Yin
Y
,
Tong
J
,
Huang
J
, et al.
Suicidal ideation, suicide attempts, and neurocognitive dysfunctions among patients with first-episode schizophrenia
.
Suicide Life Threat Behav.
2020
;
50
(
6
):
1181
1188
.

13.

Wang
W
,
Zhou
Y
,
Wang
J
, et al.
Prevalence, clinical correlates of suicide attempt and its relationship with empathy in patients with schizophrenia
.
Prog Neuropsychopharmacol Biol Psychiatry.
2020
;
99
:
109863
.

14.

Nordentoft
M
,
Mortensen
PB
,
Pedersen
CB
.
Absolute risk of suicide after first hospital contact in mental disorder
.
Arch Gen Psychiatry.
2011
;
68
(
10
):
1058
1064
.

15.

Selby
EA
,
Kranzler
A
,
Fehling
KB
,
Panza
E
.
Nonsuicidal self-injury disorder: the path to diagnostic validity and final obstacles
.
Clin Psychol Rev.
2015
;
38
:
79
91
.

16.

Cipriano
A
,
Cella
S
,
Cotrufo
P
.
Nonsuicidal self-injury: a systematic review
.
Front Psychol.
2017
;
8
:
1946
.

17.

Andover
MS
,
Morris
BW
,
Wren
A
,
Bruzzese
ME
.
The co-occurrence of non-suicidal self-injury and attempted suicide among adolescents: distinguishing risk factors and psychosocial correlates
.
Child Adolesc Psychiatry Ment Health.
2012
;
6
:
11
.

18.

Self-injury ISftSo
.
What is Self-Injury?
https://www.itriples.org/what-is-nssi. Accessed
October 25, 2022
.

19.

National Collaborating Centre for Mental H. National Institute for Health and Clinical Excellence: guidance
.
Self-Harm: The Short-Term Physical and Psychological Management and Secondary Prevention of Self-Harm in Primary and Secondary Care
. British Psychological Society Copyright © 2004,
The British Psychological Society & The Royal College of Psychiatrists
;
2004
.

20.

Halicka
J
,
Kiejna
A
.
Non-suicidal self-injury (NSSI) and suicidal: criteria differentiation
.
Adv Clin Exp Med
.
2018
;
27
(
2
):
257
261
.

21.

Taylor
PJ
,
Hutton
P
,
Wood
L
.
Are people at risk of psychosis also at risk of suicide and self-harm? A systematic review and meta-analysis
.
Psychol Med.
2015
;
45
(
5
):
911
926
.

22.

Challis
S
,
Nielssen
O
,
Harris
A
,
Large
M
.
Systematic meta-analysis of the risk factors for deliberate self-harm before and after treatment for first-episode psychosis
.
Acta Psychiatr Scand.
2013
;
127
(
6
):
442
454
.

23.

Page
MJ
,
Moher
D
,
Bossuyt
PM
, et al.
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
.
BMJ.
2021
;
372
:
n160
.

24.

Covidence Systematic Review Software
. https://www.covidence.org/. Accessed November 21, 2022.

25.

Nelson
B.
The CAARMS: Assessing Young People at Ultra High Risk of Psychosis
.
Orygen Youth Health Research Centre
;
2014
. https://www.orygen.org.au/Training/Resources/Psychosis/Manuals/CAARMS. Accessed November 21, 2022.

26.

Andreasen
NC
.
The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations
.
Br J Psychiatry Suppl.
1989
;
7
:
49
58
.

27.

Kay
SR
,
Fiszbein
A
,
Opler
LA
.
The positive and negative syndrome scale (PANSS) for schizophrenia
.
Schizophr Bull.
1987
;
13
(
2
):
261
276
.

28.

Addington
D
,
Addington
J
,
Maticka-Tyndale
E
.
Assessing depression in schizophrenia: the Calgary Depression Scale
.
Br J Psychiatry Suppl.
1993
;
22
:
39
44
.

29.

Munn
Z
,
Moola
S
,
Lisy
K
,
Riitano
D
,
Tufanaru
C
.
Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
.
Int J Evid Based Healthc.
2015
;
13
(
3
):
147
153
.

30.

Ma
LL
,
Wang
YY
,
Yang
ZH
,
Huang
D
,
Weng
H
,
Zeng
XT
.
Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?
Mil Med Res.
2020
;
7
(
1
):
7
.

31.

Egger
M
,
Davey Smith
G
,
Schneider
M
,
Minder
C
.
Bias in meta-analysis detected by a simple, graphical test
.
BMJ.
1997
;
315
(
7109
):
629
634
.

32.

Higgins
JP
,
Thompson
SG
,
Deeks
JJ
,
Altman
DG
.
Measuring inconsistency in meta-analyses
.
BMJ.
2003
;
327
(
7414
):
557
560
.

33.

RStudio: Integrated Development for R.
RStudio
.
2020
. http://www.rstudio.com/. Accessed November 21, 2022.

34.

Morgan
V
,
Korten
A
,
Jablensky
A
.
Modifiable risk factors for hospitalization among people with psychosis: evidence from the National Study of Low Prevalence (Psychotic) Disorders
.
Aust N Z J Psychiatry.
2006
;
40
(
8
):
683
690
.

35.

O’Hare
T
,
Shen
C
,
Sherrer
M
.
Lifetime trauma and suicide attempts in people with severe mental illness
.
Community Ment Health J.
2014
;
50
(
6
):
673
680
.

36.

Kasper
ME
,
Rogers
R
,
Adams
PA
.
Dangerousness and command hallucinations: an investigation of psychotic inpatients
.
Bull Am Acad Psychiatry Law.
1996
;
24
(
2
):
219
224
.

37.

Dugré
JR
,
Guay
JP
,
Dumais
A
.
Risk factors of compliance with self-harm command hallucinations in individuals with affective and non-affective psychosis
.
Schizophr Res.
2018
;
195
:
115
121
.

38.

Grattan
RE
,
Lara
N
,
Botello
RM
, et al.
A history of trauma is associated with aggression, depression, non-suicidal self-injury behavior, and suicide ideation in first-episode psychosis
.
J Clin Med.
2019
;
8
(
7
). doi:10.3390/jcm8071082.

39.

Carlson
EB
,
McDade-Montez
E
,
Armstrong
J
,
Dalenberg
C
,
Loewenstein
RJ
.
Development and initial validation of the structured interview for self-destructive behaviors
.
J Trauma Dissociation.
2013
;
14
(
3
):
312
327
.

40.

Goghari
VM
.
Personality dimensions in schizophrenia: a family study
.
Psychiatry Res.
2017
;
251
:
162
167
.

41.

Monahan
J
,
Vesselinov
R
,
Robbins
PC
,
Appelbaum
PS
.
Violence to others, violent self-victimization, and violent victimization by others among persons with a mental illness
.
Psychiatr Serv.
2017
;
68
(
5
):
516
519
.

42.

Mork
E
,
Walby
FA
,
Harkavy-Friedman
JM
, et al.
Clinical characteristics in schizophrenia patients with or without suicide attempts and non-suicidal self-harm--a cross-sectional study
.
BMC Psychiatry.
2013
;
13
:
255
.

43.

Verdolini
N
,
Murru
A
,
Attademo
L
, et al.
The aggressor at the mirror: psychiatric correlates of deliberate self-harm in male prison inmates
.
Eur Psychiatry.
2017
;
44
:
153
160
.

44.

Koyanagi
A
,
Stickley
A
,
Haro
JM
.
Psychotic-like experiences and nonsuicidal self-injury in England: results from a National Survey [corrected]
.
PLoS One.
2015
;
10
(
12
):
e0145533
.

45.

Dharmawardene
V
,
Menkes
DB
.
Violence and self-harm in severe mental illness: inpatient study of associations with ethnicity, cannabis and alcohol
.
Australas Psychiatry
.
2017
;
25
(
1
):
28
31
.

46.

Phillips
LJ
,
Nelson
B
,
Yuen
HP
, et al.
Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics
.
Aust N Z J Psychiatry.
2009
;
43
(
9
):
818
829
.

47.

Barrowcliff
AL
,
Haddock
G
.
Factors affecting compliance and resistance to auditory command hallucinations: perceptions of a clinical population
.
J Ment Health
.
2010
;
19
(
6
):
542
552
.

48.

Barrowclough
C
,
Haddock
G
,
Wykes
T
, et al.
Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial
.
BMJ.
2010
;
341
:
c6325
.

49.

Biswas
P
,
Malhotra
S
,
Malhotra
A
,
Gupta
N
.
A comparative study of clinical correlates in schizophrenia with onset in childhood, adolescence and adulthood
.
J Indian Assoc Child Adolesc Ment Health
.
2006
;
2
(
1
):
18
.

50.

Güney
E
,
Alnıak
I
,
Erkıran
M
.
Predicting factors for non-suicidal self-injury in patients with schizophrenia spectrum disorders and the role of substance use
.
Asian J Psychiatr.
2020
;
52
:
102068
.

51.

Haining
K
,
Karagiorgou
O
,
Gajwani
R
, et al.
Prevalence and predictors of suicidality and non-suicidal self-harm among individuals at clinical high-risk for psychosis: results from a community-recruited sample
.
Early Interv Psychiatry.
2021
;
15
(
5
):
1256
1265
.

52.

Harvey
SB
,
Dean
K
,
Morgan
C
, et al.
Self-harm in first-episode psychosis
.
Br J Psychiatry.
2008
;
192
(
3
):
178
184
.

53.

Heslin
M
,
Lappin
JM
,
Donoghue
K
, et al.
Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients
.
Schizophr Res.
2016
;
176
(
2–3
):
417
422
.

54.

Hunter
R
,
Cameron
R
,
Norrie
J
.
Using patient-reported outcomes in schizophrenia: the Scottish Schizophrenia Outcomes Study
.
Psychiatr Serv.
2009
;
60
(
2
):
240
245
.

55.

Jakhar
K
,
Bhatia
T
,
Saha
R
,
Deshpande
SN
.
A cross sectional study of prevalence and correlates of current and past risks in schizophrenia
.
Asian J Psychiatr.
2015
;
14
:
36
41
.

56.

Lee
JL
,
Ma
WF
,
Yen
WJ
,
Huang
XY
,
Chiang
LC
.
Predicting the likelihood of suicide attempts for rural outpatients with schizophrenia
.
J Clin Nurs.
2012
;
21
(
19–20
):
2896
2904
.

57.

Lee
TM
,
Chong
SA
,
Chan
YH
,
Sathyadevan
G
.
Command hallucinations among Asian patients with schizophrenia
.
Can J Psychiatry.
2004
;
49
(
12
):
838
842
.

58.

Markovitz
PJ
,
Calabrese
JR
,
Schulz
SC
,
Meltzer
HY
.
Fluoxetine in the treatment of borderline and schizotypal personality disorders
.
Am J Psychiatry.
1991
;
148
(
8
):
1064
1067
.

59.

Miles
H
,
Johnson
S
,
Amponsah-Afuwape
S
,
Finch
E
,
Leese
M
,
Thornicroft
G
.
Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder
.
Psychiatr Serv.
2003
;
54
(
4
):
554
561
.

60.

Mork
E
,
Mehlum
L
,
Barrett
EA
, et al.
Self-harm in patients with schizophrenia spectrum disorders
.
Arch Suicide Res.
2012
;
16
(
2
):
111
123
.

61.

Neeleman
J
,
Lewis
G
.
Religious identity and comfort beliefs in three groups of psychiatric patients and a group of medical controls
.
Int J Soc Psychiatry.
1994
;
40
(
2
):
124
134
.

62.

Nijman
HL
,
Dautzenberg
M
,
Merckelbach
HL
,
Jung
P
,
Wessel
I
,
del Campo
JA
.
Self-mutilating behaviour of psychiatric inpatients
.
Eur Psychiatry.
1999
;
14
(
1
):
4
10
.

63.

Ose
SO
,
Tveit
T
,
Mehlum
L
.
Non-suicidal self-injury (NSSI) in adult psychiatric outpatients - a nationwide study
.
J Psychiatr Res.
2021
;
133
:
1
9
.

64.

Pluck
G
,
Lekka
NP
,
Sarkar
S
, et al.
Clinical and neuropsychological aspects of non-fatal self-harm in schizophrenia
.
Eur Psychiatry.
2013
;
28
(
6
):
344
348
.

65.

Simms
J
,
McCormack
V
,
Anderson
R
,
Mulholland
C
.
Correlates of self-harm behaviour in acutely ill patients with schizophrenia
.
Psychol Psychother.
2007
;
80
(
Pt 1
):
39
49
.

66.

Upthegrove
R
,
Birchwood
M
,
Ross
K
,
Brunett
K
,
McCollum
R
,
Jones
L
.
The evolution of depression and suicidality in first episode psychosis
.
Acta Psychiatr Scand.
2010
;
122
(
3
):
211
218
.

67.

Zimbrón
J
,
Ruiz de Azúa
S
,
Khandaker
GM
, et al.
Clinical and sociodemographic comparison of people at high-risk for psychosis and with first-episode psychosis
.
Acta Psychiatr Scand.
2013
;
127
(
3
):
210
216
.

68.

Jarrett
M
,
Valmaggia
L
,
Parrott
J
, et al.
Prisoners at ultra-high-risk for psychosis: a cross-sectional study
.
Epidemiol Psychiatr Sci.
2016
;
25
(
2
):
150
159
.

69.

Salim
Z
,
Haddad
C
,
Obeid
S
,
Awad
E
,
Hallit
S
,
Haddad
G
.
Command voices and aggression in a lebanese sample patients with schizophrenia
.
Psychiatr Danub.
2021
;
33
(
1
):
27
35
.

70.

Guo
H
,
Zhong
S
,
Yue
Y
, et al.
Self-harm history, anxiety-depression, severity of disease, and insight are significantly associated with suicide risk in forensic psychiatric inpatients of China
.
Front Psychiatry.
2021
;
12
. doi:10.3389/fpsyt.2021.706416.

71.

Laporte
N
,
Ozolins
A
,
Westling
S
,
Westrin
A
,
Wallinius
M
.
Clinical characteristics and self-harm in forensic psychiatric patients
.
Front Psychiatry.
2021
;
12
:
698372
.

72.

Klonsky
ED
,
Glenn
CR
.
Assessing the functions of non-suicidal self-injury: psychometric properties of the Inventory of Statements About Self-injury (ISAS)
.
J Psychopathol Behav Assess
.
2009
;
31
(
3
):
215
219
.

73.

Sterne
JAC
,
Sutton
AJ
,
Ioannidis
JPA
, et al.
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
.
BMJ
.
2011
;
343
:
d4002
. doi:10.1136/bmj.d4002.

74.

Page
MJ
,
Sterne
JAC
,
Higgins
JPT
,
Egger
M
.
Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: a review
.
Res Synth Methods.
2021
;
12
(
2
):
248
259
.

75.

Taylor
PJ
,
Jomar
K
,
Dhingra
K
,
Forrester
R
,
Shahmalak
U
,
Dickson
JM
.
A meta-analysis of the prevalence of different functions of non-suicidal self-injury
.
J Affect Disord.
2018
;
227
:
759
769
.

76.

Kapur
N
,
Cooper
J
,
O’Connor
RC
,
Hawton
K
.
Non-suicidal self-injury v. attempted suicide: new diagnosis or false dichotomy?
Br J Psychiatry.
2013
;
202
(
5
):
326
328
.

77.

Kapur
N
,
Cooper
J
,
King-Hele
S
, et al.
The repetition of suicidal behavior: a multicenter cohort study
.
J Clin Psychiatry.
2006
;
67
(
10
):
1599
1609
.

78.

Claes
L
,
Vandereycken
W
,
Vertommen
H
.
Self-injurious behaviors in eating-disordered patients
.
Eat Behav.
2001
;
2
(
3
):
263
272
.

79.

Gholamrezaei
M
,
De Stefano
J
,
Heath
NL
.
Nonsuicidal self-injury across cultures and ethnic and racial minorities: a review
.
Int J Psychol.
2017
;
52
(
4
):
316
326
.

80.

Barendregt
JJ
,
Doi
SA
,
Lee
YY
,
Norman
RE
,
Vos
T
.
Meta-analysis of prevalence
.
J Epidemiol Community Health.
2013
;
67
(
11
):
974
978
.

81.

Schwarzer
G
,
Chemaitelly
H
,
Abu-Raddad
LJ
,
Rücker
G
.
Seriously misleading results using inverse of Freeman–Tukey double arcsine transformation in meta-analysis of single proportions
.
Res Synth Methods.
2019
;
10
(
3
):
476
483
.

82.

Warton
DI
,
Hui
FK
.
The arcsine is asinine: the analysis of proportions in ecology
.
Ecology
.
2011
;
92
(
1
):
3
10
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com